Samsung Galaxy smartwatches could benefit from continuous heart monitoring through a new patent. Regular heart rate readings would be translated into ECG readings for automated tracking.
Samsung's patent involves translating PPG signals to ECG signals for AFib detection. The technology aims for effectiveness and efficiency, providing users with analysed AFib detection results.
Samsung clarifies the need for a more reliable clinical diagnosis in continuous heart monitoring. The company is working on accurate methods based on PPG and ECG readings.
[
add
]
[
|
|
...
]